Report overview
Dextrose injection is a sterile solution used to provide your body with extra water and carbohydrates (calories from sugar). It is used when a patient is not able to drink enough liquids or when additional fluids are needed. 10% Dextrose Injection are indicated for use in adults and pediatric patients as sources of calories and water for hydration.
This report aims to provide a comprehensive presentation of the global market for 10% Dextrose Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 10% Dextrose Injection. This report contains market size and forecasts of 10% Dextrose Injection in global, including the following market information:
Global 10% Dextrose Injection Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global 10% Dextrose Injection Market Sales, 2018-2023, 2024-2032, (KL)
Global top five 10% Dextrose Injection companies in 2022 (%)
The global 10% Dextrose Injection market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
250 mL Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of 10% Dextrose Injection include B. Braun Medical Inc, ICU Medical, Baxter, Fresenius Kabi, Pfizer, Alfa Laboratories, Drugfield Pharmaceuticals Limited, Otsuka Pharmaceutical and Schwitz Biotech, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the 10% Dextrose Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global 10% Dextrose Injection Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (KL)
Global 10% Dextrose Injection Market Segment Percentages, by Type, 2022 (%)
250 mL
500 mL
1000 mL
Global 10% Dextrose Injection Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (KL)
Global 10% Dextrose Injection Market Segment Percentages, by Application, 2022 (%)
First-Aid Treatment
Sports
Trophotherapy
Others
Global 10% Dextrose Injection Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (KL)
Global 10% Dextrose Injection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies 10% Dextrose Injection revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies 10% Dextrose Injection revenues share in global market, 2022 (%)
Key companies 10% Dextrose Injection sales in global market, 2018-2023 (Estimated), (KL)
Key companies 10% Dextrose Injection sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
B. Braun Medical Inc
ICU Medical
Baxter
Fresenius Kabi
Pfizer
Alfa Laboratories
Drugfield Pharmaceuticals Limited
Otsuka Pharmaceutical
Schwitz Biotech
Outline of Major Chapters:
Chapter 1: Introduces the definition of 10% Dextrose Injection, market overview.
Chapter 2: Global 10% Dextrose Injection market size in revenue and volume.
Chapter 3: Detailed analysis of 10% Dextrose Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of 10% Dextrose Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global 10% Dextrose Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
